Skip to product information

Penn Medicine State of Art Heart Failure Course 2022

Penn Medicine State of Art Heart Failure Course 2022

Regular price $20.00 USD
Regular price $20.00 USD Sale price
SAVE Liquid error (snippets/price line 116): Computation results in '-Infinity'% Sold out
Penn Medicine State of Art Heart Failure Course 2022

Penn Medicine State of Art Heart Failure Course 2022

Regular price $20.00
Regular price $20.00 Sale price
SAVE Liquid error (snippets/price line 116): Computation results in '-Infinity'% Sold out
  • Share positive thoughts and feedback from your customer.

    Author
  • Share positive thoughts and feedback from your customer.

    Author
  • Share positive thoughts and feedback from your customer.

    Author
    View full details

    Penn Medicine State of Art Heart Failure Course 2022

    Penn Medicine State of Art Heart Failure Course 2022

    •  Include: 31 videos + 33 pdfs, size: 11.3 GB
    •  Target Audience: internist, cardiologist, surgeon, family medicine physician
    •  Sample video: contact me for sample video

    Information:

    Date & Location

    Friday, October 21, 2022, 8:30 AM – Saturday, October 22, 2022, 6:30 PM, Arthur H. Rubenstein Auditorium, Smilow Center for Translational Research and On-Line (Hybrid), Philadelphia, PA

    Course Overview

    Penn Medicine State of Art Heart Failure Course 2022

    This course will provide a comprehensive, state of the art update on the management of heart failure focusing on the recently updated ACC/AHA Heart Failure Management Guidelines. The course is divided into six threads each focusing on a unique aspect of heart failure management from medical and device therapies, recognition of unique etiologies of heart failure, management of cardiogenic shock and selection for advanced therapies including transplant and ventricular assist devices. Each thread will have one or more cases to illustrate diagnostic and therapeutic challenges followed by panel discussions and audience participation to make the material actionable in daily practice.

    Two keynote speakers, one each day, will provide a visionary overview of the days’ topics and provide valuable perspective from a thought leader. A unique aspect of this course will be a mock patient selection committee meeting for heart transplant and ventricular assist device to include a representative of each of the disciplines present during these life and death deliberations.

    This will be an opportunity to see, first hand, how patients are presented and which clinical and psychosocial aspects are considered in advanced therapy patient selection. The program includes a debate as well as a presentation from a patient who had a ventricular assist device and went on to have a heart transplant. The faculty will include heart failure cardiologists, interventional cardiologists, cardiothoracic surgeons, electrophysiologists, advanced practice providers, social workers, a patient and other members of the Heart Team.

    Target Audience
    Penn Medicine
    Specialties – EMERGENCY MEDICINE – Internal Medicine-Critical Care Medicine, FAMILY MEDICINE, FAMILY MEDICINE – Geriatric Medicine, INTERNAL MEDICINE, INTERNAL MEDICINE – Advanced Heart Failure and Transplant Cardiology, INTERNAL MEDICINE – Clinical Cardiac Electrophysiology, INTERNAL MEDICINE – Geriatric Medicine, INTERNAL MEDICINE – Hospice and Palliative Medicine, INTERNAL MEDICINE – Interventional Cardiology, MEDICAL GENETICS AND GENOMICS – Medical Biochemical Genetics, THORACIC AND CARDIAC SURGERY
    Learning Objectives

    After completing this activity, participants should be able to:

    1. Describe evidence based therapies for the treatment of heart failure including SGLT-2 inhibitors and soluable guanylate cyclase activators
    2. Explain how to increase the percent of patients with heart failure with reduced ejection fraction receiving all 4 guideline directed classes of medications
    3. Describe evidence based therapies for hypertrophic cardiomyopathy and amyloid cardiomyopathy
    4. Explain the indications for TAVR and mitral valve edge to edge repairs
    5. Explain the indications for remote monitoring of heart failure patients
    6. Formulate appropriate approaches to overcoming barriers to achieving heart failure guideline directed medical and device therapies
    7. Identify patients who may benefit from cardiac contractility management, biventricular pacing and ICD’s
    8. Describe patient characteristics that are associated with improved outcomes following revascularization procedures
    9. Identify evidence based therapies for heart failure with preserved ejection fraction
    10. Describe the impact of COVID-19 on the heart
    11. Explain the mechanisms of action and cardiac risks of cancer chemotherapeutic agents
    12. Identify clinical, laboratory, imaging and psychosocial factors that predict outcome in heart transplant and ventricular assist devices
    13. Describe the use of genetic testing in identifying genetic causes of cardiomyopathy
    14. Identify when to refer a patient to a multidisciplinary heart failure program
    15. Describe the roles and responsibilities of members of the interprofessional heart failure team

    Penn Medicine

    Topics:

    • Acute Shock and Shock Team.mp4
    • Acute Shock and Shock Team.pdf
    • Advanced Therapies Selection Meeting ‘The Chosen Ones’.mp4
    • Advanced Therapies Selection Meeting ‘The Chosen Ones’.pdf
    • Amyloid – ‘Gumming up the Works’.mp4
    • Amyloid – ‘Gumming up the Works’.pdf
    • Cardiac Effects of COVID – ‘Pandemic Palpitations’.mp4
    • Cardiac Effects of COVID – ‘Pandemic Palpitations’.pdf
    • Cardio-Oncology ‘Good Drugs Gone Bad’.mp4
    • Cardio-Oncology ‘Good Drugs Gone Bad’.pdf
    • Case 1.mp4
    • Case 1.pdf
    • Case 2.mp4
    • Case 2.pdf
    • Case 3.mp4
    • Case 3.pdf
    • Case 4.mp4
    • Case 4.pdf
    • Comorbidites in Heart Failure.mp4
    • Comorbidites in Heart Failure.pdf
    • Debate – VAD Outcomes are as Good as Heart Transplant ‘It’s a Wash’.pdf
    • Debate – VAD Outcomes are as Good as Heart Transplant “It’s a Wash”.mp4
    • Debate – VAD Outcomes are as Good as Heart Transplant “It’s a Wash”.pdf
    • Devices to Help the Failing Heart – ‘Just a Lttle Clip’.mp4
    • Devices to Help the Failing Heart – ‘Just a Lttle Clip’.pdf
    • EP and Heart Failure – ‘Keeping the Beat’.mp4
    • EP and Heart Failure – ‘Keeping the Beat’.pdf
    • Genetic Dilated Cardimyopathy – ‘It’s in the Genes’.pdf
    • Heart Transplant – ‘Change of Heart’.mp4
    • Heart Transplant – ‘Change of Heart’.pdf
    • HF22_Brochure_v13.pdf
    • HFpEF – Finally Something to do.pdf
    • Hypertrophic Cardiomyopathy.pdf
    • Keynote- Cardiogenic Shock- Principles, Progress and Future Prospects.mp4
    • Keynote- Cardiogenic Shock- Principles, Progress and Future Prospects.pdf
    • KEYNOTE- The New AHA ACC HFSA Heart Failure Guidelines.mp4
    • KEYNOTE- The New AHA ACC HFSA Heart Failure Guidelines.pdf
    • Living with Heart Failure (or MCS or Transplant) – ‘No Pulse No Problem’.mp4
    • Living with Heart Failure (or MCS or Transplant) – ‘No Pulse No Problem’.pdf
    • Mechanical Circulatory Support – ‘Go with the Continuous Flow’.mp4
    • Mechanical Circulatory Support – ‘Go with the Continuous Flow’.pdf
    • New Heart Failure Guidelines.mp4
    • New Heart Failure Guidelines.pdf
    • New Technologies That Might Just Work.mp4
    • New Technologies That Might Just Work.pdf
    • Novel Drugs.mp4
    • Novel Drugs.pdf
    • Overcoming Barriers to Advanced Therapies.mp4
    • Overcoming Barriers to Advanced Therapies.pdf
    • Panel Discussion with Q&A.mp4
    • Pulmonary Hypertension and Right Ventricular Failure.mp4
    • Pulmonary Hypertension and Right Ventricular Failure.pdf
    • Remote Monitoring – ‘Keeping my eye on you’.mp4
    • Remote Monitoring – ‘Keeping my eye on you’.pdf
    • Revascularization.mp4
    • Revascularization.pdf
    • Sarcoid – ‘My Heart is on Fire’.mp4
    • Sarcoid – ‘My Heart is on Fire’.pdf
    • SGLT-2 Inhibitors and Vericiguat ‘How Sweet it is!’.mp4
    • SGLT-2 Inhibitors and Vericiguat ‘How Sweet it is!’.pdf
    • Systolic Heart Failure – How to Achieve Myocardial Recovery Panel Discussion with Q&A 1.mp4
    • Systolic Heart Failure – How to Achieve Myocardial Recovery Panel Discussion with Q&A 2.mp4
    • Valve Surgery.mp4
    • Valve Surgery.pdf